Impact of Toxicity on Survival for Older Adult Patients after CD34(+) Selected Allogeneic Hematopoietic Stem Cell Transplantation

Shah, GL; Scordo, M; Kosuri, S; Herrera, DA; Cho, C; Devlin, SM; Borrill, T; Carlow, DC; Avecilla, ST; Meagher, RC; O'Reilly, RJ; Jakubowski, AA; Papadopoulos, EB; Koehne, G; Gyurkocza, B; Castro-Malaspina, H; Shaffer, BC; Perales, MA; Giralt, SA; Ta

Shah, GL (reprint author), Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, 1275 York Ave,Box 298, New York, NY 10065 USA.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018; 24 (1): 142

Abstract

Ex vivo CD34(+) selection before allogeneic hematopoietic stem cell transplantation (allo-HCT) reduces graft-versus-host disease without increasing re......

Full Text Link